Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent ef- fect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. 2004;164:1422 1426. doi: 251. Banerjee C, Moon YP, Paik MC, Rundek T, Mora-McLaughlin C, Vieira JR, Sacco RL, Elkind MS. Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study. Stroke. 2012;43:1212 1217. doi: 252. Mitsios JP, Ekinci EI, Mitsios GP, Churilov L, Thijs V. Relationship between glycated hemoglobin and stroke risk: a systematic review and meta-analy- sis. J Am Heart Assoc. 2018;7:e007858. doi: 10.1161/JAHA.117.00785 253. Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Schmidt MI, Heiss G. Prospective associations of fasting insulin, body fat distribu- tion, and diabetes with risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study investigators. Diabetes Care. 1999;22:1077 254. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL. Glycated hemoglobin, diabetes, and cardiovas- cular risk in nondiabetic adults. N Engl J Med. 2010;362:800 811. doi: 255. Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Bravata DM, Shulman GI, McVeety JC. Prevalence of abnormal glucose tolerance following a tran- sient ischemic attack or ischemic stroke. Arch Intern Med. 2005;165:227 256. Pan Y, Chen W, Wang Y. Prediabetes and outcome of ischemic stroke or transient ischemic attack: a systematic review and meta-analy- sis. J Stroke Cerebrovasc Dis. 2019;28:683 692. doi: 10.1016/j. 257. Hier DB, Foulkes MA, Swiontoniowski M, Sacco RL, Gorelick PB, Mohr JP, Price TR, Wolf PA. Stroke recurrence within 2 years after ischemic infarc- tion. Stroke. 1991;22:155 161. doi: 10.1161/01.str.22.2.155 258. 